Skip to main content

Plaintiff Allowed to Present Evidence in 2nd IVC Filter Case

Plaintiff Allowed to Present Evidence in 2nd IVC Filter Case

Plaintiff Allowed to Present Evidence in 2nd IVC Filter Case

Introduction

The U.S. Federal Judge David G. Campbell, overseeing thousands of IVC Filter lawsuits centralized in the United States District Court District of Arizona, released a Case Management Order on April 18, allowing the plaintiff to present evidence of complications, testing, and design of the Recovery filter stating it would not result in a waste of time or confusion except. At the same time, evidence that highlighted the deaths caused by cephalad migration of the Recovery filter was not allowed to be part of the supporting evidence.
 
This is the second Bard IVC filter lawsuit scheduled for a May 15, 2018, trial, filed by a plaintiff from Georgia, who was implanted with C.R. Bard’s Eclipse blood clot filter in 2010 to treat her recurrent deep vein thrombosis condition. A pretrial conference is scheduled for May 4 and the expected trial run is 3 weeks.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!